Eiser Christine, Absolom Kate, Greenfield Diana, Glaser Adam, Horne Beverly, Waite Heather, Urquhart Tanya, Wallace W Hamish B, Ross Richard, Davies Helena
Department of Psychology, University of Sheffield, Western Bank, and Academic Unit of Clinical Oncology, Cancer Research Centre, Weston Park Hospital, Sheffield S10 2TP, United Kingdom.
Eur J Cancer. 2006 Dec;42(18):3186-90. doi: 10.1016/j.ejca.2006.08.001. Epub 2006 Sep 20.
Follow-up for cancer survivors is recommended to detect recurrence; monitor late-effects; record toxicity and provide care and education. We describe our experience with a three-level model developed to guide decisions about intensity and frequency of follow-up [Wallace WHB, Blacklay A, Eiser C, et al. Developing strategies for the long term follow-up of survivors of childhood cancer. BMJ 2001;323:271-274].
One hundred and ninety eight survivors (52% male) recruited over 12-months: (mean age=23.8 years, range=16-39 years; mean time since diagnosis=16.2 years, range 2.4-32.7 years) reported their number of symptoms and late-effects. Information was taken from the medical records to assign each survivor to the appropriate levels by six clinic staff independently.
The survivors were assigned to level 1 (n=8), level 2 (n=97) and level 3 (n=93). There were seven cases of disagreement. Level 3 survivors self-reported more symptoms and late-effects than level 2 survivors.
Coding was relatively simple for experienced clinic staff, although there were some disagreements for the survivors of ALL. The relationship between assigned level and self-reported symptoms and late-effects provides some evidence for validity of the model. We conclude that it is important to maintain flexibility to allow movement between levels for individual patients and that the default should always be to the higher level.
建议对癌症幸存者进行随访,以检测复发情况;监测远期效应;记录毒性反应,并提供护理和教育。我们描述了我们使用一种三级模型的经验,该模型旨在指导关于随访强度和频率的决策[华莱士·W·H·B、布莱克莱·A、艾泽尔·C等。制定儿童癌症幸存者长期随访策略。《英国医学杂志》2001年;323:271 - 274]。
在12个月内招募了198名幸存者(52%为男性):(平均年龄 = 23.8岁,范围 = 16 - 39岁;自诊断以来的平均时间 = 16.2年,范围2.4 - 32.7年)报告了他们的症状数量和远期效应。六名诊所工作人员独立从医疗记录中获取信息,将每位幸存者分配到相应级别。
幸存者被分配到1级(n = 8)、2级(n = 97)和3级(n = 93)。有7例存在分歧。3级幸存者自我报告的症状和远期效应比2级幸存者更多。
对于经验丰富的诊所工作人员来说,编码相对简单,尽管在急性淋巴细胞白血病幸存者中存在一些分歧。分配级别与自我报告的症状和远期效应之间的关系为该模型的有效性提供了一些证据。我们得出结论,重要的是要保持灵活性,允许个体患者在不同级别之间变动,并且默认设置应始终为较高级别。